United Kingdom (UK) Central Nervous System Therapeutic Market (2025-2031) | Growth, Outlook, Forecast, Segmentation, Share, Industry, Size & Revenue, Trends, Competitive Landscape, Analysis, Companies, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Central Nervous System Therapeutic Market - Industry Life Cycle

3.4 United Kingdom (UK) Central Nervous System Therapeutic Market - Porter's Five Forces

3.5 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume Share, By Disease, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders in the UK

4.2.2 Growing awareness about mental health and the importance of seeking treatment

4.2.3 Advances in technology leading to the development of innovative CNS therapies

4.3 Market Restraints

4.3.1 Stringent regulations and lengthy approval processes for new CNS drugs in the UK

4.3.2 High cost associated with CNS therapies impacting affordability for patients

4.3.3 Limited access to specialized healthcare professionals for CNS disorders in some regions of the UK

6.1 United Kingdom (UK) Central Nervous System Therapeutic Market, By Disease

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume, By Disease, 2021- 2031F

6.1.3 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume, By Neurovascular Diseases, 2021- 2031F

6.1.4 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume, By CNS Trauma, 2021- 2031F

6.1.5 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume, By Mental Health, 2021- 2031F

6.1.6 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F

6.1.7 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.1.8 United Kingdom (UK) Central Nervous System Therapeutic Market Revenues & Volume, By CNS Cancer, 2021- 2031F

7.1 United Kingdom (UK) Central Nervous System Therapeutic Market Export to Major Countries

7.2 United Kingdom (UK) Central Nervous System Therapeutic Market Imports from Major Countries

8.1 Number of clinical trials for CNS therapies being conducted in the UK

8.2 Adoption rate of telemedicine services for CNS consultations

8.3 Patient satisfaction scores with CNS treatment outcomes

9.1 United Kingdom (UK) Central Nervous System Therapeutic Market Opportunity Assessment, By Disease, 2021 & 2031F

10.1 United Kingdom (UK) Central Nervous System Therapeutic Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Central Nervous System Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters